yzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today reported financial results for the fourth quar...
Read moreThis pathology, common among patients who have undergone rectal resection due to cancer, causes alterations in bowel function with great impact on quality of life.
Read moreEl grupo de investigación Bioingeniería en Regeneración y Cáncer del Instituto de Investigación Sanitaria Biogipuzkoa, dirigido por la Dra. Amaia Cipitria e investigadora IKERBASQUE, ha publicado...
Read moreA partir de las evidencias científicas disponibles hasta el momento, la Sociedad Americana de Oncología Clínica ha actualizado sus recomendaciones consenso sobre el análisis de mutaciones germinal...
Read moreParticipan en la iniciativa europea ‘Acción Conjunta para la prevención del cáncer y otras enfermedades no transmisibles’ para promover hábitos de vida saludables, especialmente en colectivos ...
Read moreLas dos instituciones han firmado un convenio centrado en tres proyectos científicos sobre estrategias combinadas de inmunoterapia, moléculas para estimular el sistema inmune y terapias CAR-T
Read moreThe independent data monitoring committee (IDMC) has recommended continuation of CLINGLIO without modification after its assessment of LAM561 interim efficacy in newly diagnosed Glioblastoma. This fol...
Read moreEndowed with 1.25 million euros, the project is coordinated by IDIBAPS’ Clinical Addictions Research Group (GRAC-GRE), which is led by Hugo López-Pelayo, a researcher and medical specialist at Hosp...
Read moreIn an international study, they propose optimizing the design of clinical trials in rare tumors to speed up the study and approval of new drugs that will make it possible to respond to patients with t...
Read moreThe study analyzes data from women with pathogenic variants of the BRCA1 or BRCA2 genes and shows that those with BRCA1 sequence variations undergoing magnetic resonance imaging follow-up have a signi...
Read moreThe DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of lif...
Read more